Percentage of Graduates Entering GME Stable Over Past Decade

Share this content:
Percentage of Graduates Entering GME Stable Over Past Decade
Percentage of Graduates Entering GME Stable Over Past Decade

WEDNESDAY, Dec. 9, 2015 (HealthDay News) -- Despite an increase in the number of U.S. medical school graduates, over the past decade the percentage entering graduate medical education (GME) training has remained stable, according to a research letter published in the Dec. 8 issue of the Journal of the American Medical Association, a theme issue on medical education.

Henry M. Sondheimer, M.D., from the Association of American Medical Colleges in Washington, D.C., and colleagues identified all graduates from the Association of American Medical Colleges Student Record System. They examined whether graduates from all medical schools entered GME training; the percentage of graduates unplaced in GME was assessed overall and by race/ethnicity.

The researchers found that during the study period there were 186,937 graduates, increasing from 15,762 in 2004-2005 to 18,705 in 2014-2015. The percentage of graduates unplaced in GME during the academic year of their graduation from medical school was stable over time, with a mean of 3.0 percent (P = 0.18 for trend). Over time, there was an increase in unplaced black, Hispanic, and non-U.S. citizen graduates. Compared with whites, racial/ethnic minority graduates were consistently less likely to begin GME the year they graduated. More than 99 percent of all graduates entered GME or were found in medical practice in the United States within six years after graduation.

"As the number of U.S. MD graduates continues to increase with the creation of new medical schools and the growth of existing schools, these trends should be closely monitored," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »